Shares of Ind Swift Laboratories were locked in upper circuit after the deal with PI Industries fell through

Why shares of PI Industries are down 8% today? Good time to buy?

PI Industries slumped 7.07% to Rs 2,784.55 after the company announced termination of business transfer agreement agreement with Ind Swift Laboratories and its promoters.

PI Industries decline after terminating business transfer agreement with Ind Swift

Acquisition of Ind Swift Laboratories would provide synergistic benefits and would be new growth catalyst for the company. Company believes the acquisition is the first step towards transforming itself into a more diversified player.

PI Industries: A Sizeable Entry Into Pharma

Agri-science firm PI Industries on Saturday said it has agreed to acquire Ind Swift Laboratories’ active pharmaceutical ingredients (API) business for an enterprise value of Rs 1,530 crore.In a regulatory filing, PI Industries said the company has “executed a business transfer agreement wi…

PI Industries to acquire Ind Swift’s API biz for Rs 1,530 cr

PI Industries (PI) expects to create significant value by leveraging combined capabilities and unlock synergies. The API business of ISLL has diversified portfolio of 20+ products with leadership position (global top 5) in several of them and a

P I Industries to acquire API business of Ind Swift Laboratories

BRIEF-India’s IND Swift Laboratories Posts Dec-Quarter Consol Net PAT

The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.

BRIEF-Ind Swift Laboratories Posts Sept-Qtr Consol Net Profit - Investing.com India

BRIEF-Ind Swift Laboratories To Launch Generic Fexofenadine In U.S. Market - Investing.com India

Hasn't fared well - amongst the low performers

Performance

Undervalued compared to the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is underpriced and is not in the overbought zone

Current price is less than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Ind-Swift Laboratories Limited is a company focused on the development of active pharmaceutical ingredients (APIs).